Medico Remedies Limited (MEDICO) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.010x

Based on the latest financial reports, Medico Remedies Limited (MEDICO) has a cash flow conversion efficiency ratio of 0.010x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rs6.43 Million ≈ $69.54K USD) by net assets (Rs668.58 Million ≈ $7.23 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Medico Remedies Limited balance sheet independence to measure how much of total assets are equity-financed.

Medico Remedies Limited - Cash Flow Conversion Efficiency Trend (2013–2026)

This chart illustrates how Medico Remedies Limited's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Medico Remedies Limited cash earnings quality to evaluate the quality of earnings relative to operating cash generation.

Medico Remedies Limited Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Medico Remedies Limited ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Plastiques du Val de Loire
PA:PVL
0.215x
Korea Computer Inc
KQ:054040
0.041x
Kwang Ming Silk Mill Co Ltd
TWO:4420
-0.105x
S&S Power Switchgears Limited
NSE:S&SPOWER
-0.185x
HPQ Silicon Resources Inc
V:HPQ
-0.051x
TPXIMPACT HOLDINGS LS-01
F:9L7
N/A
Cs Holdings
KO:000590
0.007x
Apollo Power Ltd
TA:APLP
-0.074x

Annual Cash Flow Conversion Efficiency for Medico Remedies Limited (2013–2026)

The table below shows the annual cash flow conversion efficiency of Medico Remedies Limited from 2013 to 2026. For the full company profile with market capitalisation and key ratios, see Medico Remedies Limited (MEDICO) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2026-03-31 Rs754.74 Million
≈ $8.16 Million
Rs10.06 Million
≈ $108.82K
0.013x -82.98%
2025-03-31 Rs624.69 Million
≈ $6.76 Million
Rs48.92 Million
≈ $529.06K
0.078x +68.23%
2024-03-31 Rs523.71 Million
≈ $5.66 Million
Rs24.38 Million
≈ $263.65K
0.047x -75.01%
2023-03-31 Rs438.43 Million
≈ $4.74 Million
Rs81.67 Million
≈ $883.25K
0.186x +18.60%
2022-03-31 Rs373.20 Million
≈ $4.04 Million
Rs58.62 Million
≈ $633.95K
0.157x +145.08%
2021-03-31 Rs324.58 Million
≈ $3.51 Million
Rs-113.10 Million
≈ $-1.22 Million
-0.348x -1175.78%
2020-03-31 Rs298.66 Million
≈ $3.23 Million
Rs9.67 Million
≈ $104.62K
0.032x -81.43%
2019-03-31 Rs282.36 Million
≈ $3.05 Million
Rs49.24 Million
≈ $532.54K
0.174x -8.75%
2018-03-31 Rs266.66 Million
≈ $2.88 Million
Rs50.97 Million
≈ $551.17K
0.191x +202.51%
2017-03-31 Rs163.72 Million
≈ $1.77 Million
Rs-30.52 Million
≈ $-330.12K
-0.186x +26.28%
2016-03-31 Rs147.44 Million
≈ $1.59 Million
Rs-37.29 Million
≈ $-403.27K
-0.253x -980.71%
2015-03-31 Rs136.14 Million
≈ $1.47 Million
Rs-3.19 Million
≈ $-34.46K
-0.023x -107.36%
2014-03-31 Rs85.72 Million
≈ $927.00K
Rs27.27 Million
≈ $294.96K
0.318x -21.78%
2013-03-31 Rs50.55 Million
≈ $546.71K
Rs20.57 Million
≈ $222.40K
0.407x --

About Medico Remedies Limited

NSE:MEDICO India Drug Manufacturers - Specialty & Generic
Market Cap
$44.57 Million
Rs4.12 Billion INR
Market Cap Rank
#22282 Global
#1241 in India
Share Price
Rs49.66
Change (1 day)
+1.62%
52-Week Range
Rs32.76 - Rs54.24
All Time High
Rs96.70
About

Medico Remedies Limited develops, manufactures, and sells pharmaceutical and nutraceutical products in India. The company offers antibiotics and anti-infectives; beta-lactams-penicillins and cephalosporins; antifungals; vitamins and supplements; cardiovascular products; antipyretic, analgesic, and NSAIDs medicines; antacid and anti-ulcer drugs; antidepressants, antipsychotics, and anti-epileptics… Read more